Brief: Ginkgo Bioworks Acquires Reverie Labs Platform, Enhancing AI-Driven Drug Discovery Capabilities for Customer Programs
28/02/2024 12:13
Feb 28 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N :
* GINKGO BIOWORKS ACQUIRES REVERIE LABS PLATFORM, ENHANCING
AI-DRIVEN DRUG DISCOVERY CAPABILITIES FOR CUSTOMER PROGRAMS
* GINKGO BIOWORKS- ACQUIRED REVERIE'S SOFTWARE FOR TRAINING
LARGE-SCALE AI FOUNDATION MODELS AND 4 REVERIE AI TEAM MEMBERS
WILL JOIN CO
Source text for Eikon: ID:nPn9nKm36a
Further company coverage: DNA.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ginkgo Bioworks Holdings
See all newsUS STOCKS ON THE MOVE-NiSource, Hewlett Packard, Sandisk
US STOCKS ON THE MOVE-CoreWeave, Moderna, Fox Corp
Brief: Ginkgo Bioworks To Provide Autonomous Lab Access To Nsf X-Labs Researchers
US weighs allowing most pharma licensing deals with China, sources say
Ginkgo Bioworks Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary